Celularity Inc. CELU
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 18.97M | 26.55M | 40.58M | 44.59M | 50.97M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.97M | 26.55M | 40.58M | 44.59M | 50.97M |
| Cost of Revenue | 17.97M | 20.07M | 20.04M | 20.02M | 16.90M |
| Gross Profit | 998.00K | 6.48M | 20.54M | 24.57M | 34.06M |
| SG&A Expenses | 46.17M | 51.27M | 52.26M | 55.60M | 58.88M |
| Depreciation & Amortization | -418.00K | -418.00K | 1.44M | 1.49M | 1.58M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 78.01M | 85.95M | 89.25M | 91.94M | 92.63M |
| Operating Income | -59.04M | -59.40M | -48.67M | -47.35M | -41.66M |
| Income Before Tax | -71.09M | -91.71M | -80.65M | -73.67M | -55.63M |
| Income Tax Expenses | 3.00K | 3.00K | -- | -- | -- |
| Earnings from Continuing Operations | -71.09 | -91.72 | -80.65 | -73.67 | -55.63 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -71.09M | -91.72M | -80.65M | -73.67M | -55.63M |
| EBIT | -59.04M | -59.40M | -48.67M | -47.35M | -41.66M |
| EBITDA | -52.49M | -52.61M | -41.36M | -39.91M | -34.06M |
| EPS Basic | -2.73 | -3.60 | -3.34 | -3.19 | -2.47 |
| Normalized Basic EPS | -1.55 | -1.94 | -1.90 | -1.80 | -1.38 |
| EPS Diluted | -2.74 | -3.60 | -3.34 | -3.19 | -2.47 |
| Normalized Diluted EPS | -1.55 | -1.94 | -1.90 | -1.80 | -1.38 |
| Average Basic Shares Outstanding | 107.89M | 102.35M | 96.19M | 91.82M | 89.65M |
| Average Diluted Shares Outstanding | 109.12M | 102.35M | 96.19M | 91.82M | 89.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |